Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Evaluating Safety and Efficacy of Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Adenocarcinoma

NCT01025570 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01025570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01025570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Evaluating Safety and Efficacy of Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Adenocarcinoma
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Terminated
Start date
May 31, 2010
Completion date
June 30, 2013
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer